in controls and therefore observed an identical rate (0.9%) of de novo CNVs in 426 controls. Three out of four de novo events overlapped between two groups. One de novo event that was unique to each group was < 20 kb in size. These comparisons showed that our method had high sensitivity in identifying de novo CNVs in different size classes.
